Picture of ReGen Biologics logo

RGBOQ ReGen Biologics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for ReGen Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2004
December 31st
2005
December 31st
2006
December 31st
C2007
December 31st
2008
December 31st
Period Length:
Source:10-K/A10-K/A10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments12.213.37.924.110.25
Net Total Accounts Receivable
Net Total Receivables0.0440.050.0830.2360.233
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets12.5148.574.991.86
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0550.2050.3210.4020.328
Long Term Investments
Other Long Term Assets
Total Assets12.714.59.035.52.29
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1.192.651.340.65512
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities8.3510.19.189.0512.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity4.374.46-0.144-3.54-9.91
Total Liabilities & Shareholders' Equity12.714.59.035.52.29
Total Common Shares Outstanding
Total Preferred Shares Outstanding